NKCL’s Technological Competitiveness

High NK cell yield

The key to commercialization of NK cell therapy is the technology to cultivate cells in large quantities. This is because NK cells are more difficult and difficult to cultivate than other immune cells such as T cells, and a larger amount of NK cells must be introduced to remove cancer cells and disease-causing cells generated in the human body. NKCL dramatically increased the number of NK cell cultures through the specialization of culture environment manufacturing technology and culture source technology optimized for NK cell culture. Each individual has a different culture environment optimized for cell culture. NKCL built a database of 12 optimal culture environment recipes by mixing various environments required for culture, such as temperature, humidity, culture components, and enzyme concentration. Compared to the previous method that could cultivate 200 to 400 million cells, the average number of NK cell cultures was achieved with 10 billion cells.

Links to Refer
🌐 Official Website: http://nkclc.com/
📨 Telegram: https://t.me/nkclc
📣 Twitter: https://twitter.com/nkclcofficial
📊 Xangle: https://xangle.io/project/NKCLC/key-info
📱 Youtube: https://www.youtube.com/channel/UCsWJKXXmny-PlUtvRz6Qb_w